Atenolol, >=98% (TLC), powder

Code: A7655-1G D2-231

Application

Atenolol is a β-adrenergic blocker and used in the management of hypertension. Atenolol has antianginal and antiarrhythmic properties.

Biochem/...


 Read more

Your Price
€86.13 1G
€105.94 inc. VAT

Application

Atenolol is a β-adrenergic blocker and used in the management of hypertension. Atenolol has antianginal and antiarrhythmic properties.

Biochem/physiol Actions

Selective β1-adrenoceptor antagonist; antihypertensive; antianginal; antiarrhythmic.

Features and Benefits

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is featured on the β-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Other Notes

Shelf-life of the solid is at least three years.

assay≥98% (TLC)
colorwhite to off-white
formpowder
Gene Informationhuman ... ADRB1(153)rat ... Adrb1(24925)
InChI keyMETKIMKYRPQLGS-UHFFFAOYSA-N
InChI1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
originatorAstraZeneca
Quality Level200
SMILES stringCC(C)NCC(O)COc1ccc(CC(N)=O)cc1
solubilityethanol: 3.4 mg/mL, H2O: 0.3 mg/mL, DMSO: 18 mg/mL
Cas Number29122-68-7
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.